Literature DB >> 14085007

NORMOTHYMOTICS, "MOOD-NORMALIZERS": ARE LITHIUM AND THE IMIPRAMINE DRUGS SPECIFIC FOR AFFECTIVE DISORDERS?

M SCHOU.   

Abstract

Entities:  

Keywords:  DEPRESSION; ELECTROCARDIOGRAPHY; EMOTIONS; IMIPRAMINE; LITHIUM; PSYCHOSES, MANIC-DEPRESSIVE

Mesh：

Substances：

Year:  1963        PMID： 14085007     DOI： 10.1192/bjp.109.463.803

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  8 in total

Review 1.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

2.  Lithium psychiatry : therapeutic efficacy, side effects and practical issues.

Authors:  S K Khandelwal
Journal:  Indian J Psychiatry       Date:  1991-07       Impact factor: 1.759

3.  Lithium stops hereditary shuddering in Drosophila melanogaster.

Authors:  R L Williamson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Effect of low-dose lithium administration and subsequent withdrawal on biogenic amines in rat brain.

Authors:  P Ahluwalia; R L Singhal
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

Review 5.  Lithium in the treatment of major depressive disorder.

Authors:  Tom Bschor
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

Review 6.  Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders.

Authors:  D Healy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Effect of lithium administration on rat brain 5-hydroxyindole levels in a possible animal model for mania.

Authors:  A L Vale; F Ratcliffe
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 8.  The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.

Authors:  Konstantinos N Fountoulakis; Allan Young; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Pierre Blier; Hans Jurgen Moeller; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.